Chlorine in PDB 8b8z: Crystal Structure of Mutant Pparg (C313A) and NCOR2 with An Inverse Agonist (Compound 7E)
Protein crystallography data
The structure of Crystal Structure of Mutant Pparg (C313A) and NCOR2 with An Inverse Agonist (Compound 7E), PDB code: 8b8z
was solved by
A.Friberg,
D.L.Orsi,
E.Pook,
S.Siegel,
C.T.Lemke,
T.Stellfeld,
V.Puetter,
J.Goldstein,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
49.17 /
2.22
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
59.802,
85.667,
120.076,
90,
90,
90
|
R / Rfree (%)
|
19.6 /
24.8
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of Mutant Pparg (C313A) and NCOR2 with An Inverse Agonist (Compound 7E)
(pdb code 8b8z). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Crystal Structure of Mutant Pparg (C313A) and NCOR2 with An Inverse Agonist (Compound 7E), PDB code: 8b8z:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 8b8z
Go back to
Chlorine Binding Sites List in 8b8z
Chlorine binding site 1 out
of 4 in the Crystal Structure of Mutant Pparg (C313A) and NCOR2 with An Inverse Agonist (Compound 7E)
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of Mutant Pparg (C313A) and NCOR2 with An Inverse Agonist (Compound 7E) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1001
b:57.0
occ:1.00
|
CL16
|
A:Q331001
|
0.0
|
57.0
|
1.0
|
C15
|
A:Q331001
|
1.7
|
59.5
|
1.0
|
C17
|
A:Q331001
|
2.7
|
59.0
|
1.0
|
C14
|
A:Q331001
|
2.7
|
54.5
|
1.0
|
CL1
|
A:Q331001
|
3.0
|
60.6
|
1.0
|
CD2
|
A:LEU353
|
3.8
|
38.8
|
1.0
|
C10
|
A:Q331001
|
4.0
|
60.5
|
1.0
|
C12
|
A:Q331001
|
4.0
|
55.1
|
1.0
|
CZ
|
A:PHE363
|
4.0
|
61.5
|
1.0
|
CD1
|
A:LEU353
|
4.1
|
38.1
|
1.0
|
CG
|
A:MET364
|
4.2
|
37.7
|
1.0
|
CG2
|
A:ILE281
|
4.3
|
42.7
|
1.0
|
CE
|
A:MET364
|
4.5
|
38.8
|
1.0
|
SD
|
A:MET348
|
4.5
|
52.5
|
1.0
|
C11
|
A:Q331001
|
4.5
|
58.2
|
1.0
|
SD
|
A:MET364
|
4.5
|
40.7
|
1.0
|
CG
|
A:LEU353
|
4.5
|
37.8
|
1.0
|
CG1
|
A:VAL339
|
4.6
|
32.6
|
1.0
|
CB
|
A:ALA285
|
4.6
|
40.3
|
1.0
|
CE2
|
A:PHE363
|
4.6
|
63.4
|
1.0
|
CG2
|
A:ILE341
|
4.7
|
42.5
|
1.0
|
CE1
|
A:PHE363
|
4.8
|
67.1
|
1.0
|
CE
|
A:MET348
|
4.9
|
47.5
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 8b8z
Go back to
Chlorine Binding Sites List in 8b8z
Chlorine binding site 2 out
of 4 in the Crystal Structure of Mutant Pparg (C313A) and NCOR2 with An Inverse Agonist (Compound 7E)
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of Mutant Pparg (C313A) and NCOR2 with An Inverse Agonist (Compound 7E) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1001
b:60.6
occ:1.00
|
CL1
|
A:Q331001
|
0.0
|
60.6
|
1.0
|
C17
|
A:Q331001
|
1.7
|
59.0
|
1.0
|
C15
|
A:Q331001
|
2.6
|
59.5
|
1.0
|
C10
|
A:Q331001
|
2.7
|
60.5
|
1.0
|
CL16
|
A:Q331001
|
3.0
|
57.0
|
1.0
|
N3
|
A:Q331001
|
3.1
|
51.7
|
1.0
|
C2
|
A:Q331001
|
3.2
|
55.2
|
1.0
|
CE
|
A:MET364
|
3.6
|
38.8
|
1.0
|
CD2
|
A:LEU330
|
3.8
|
44.9
|
1.0
|
C14
|
A:Q331001
|
4.0
|
54.5
|
1.0
|
C11
|
A:Q331001
|
4.0
|
58.2
|
1.0
|
O1
|
A:Q331001
|
4.1
|
62.0
|
1.0
|
C4
|
A:Q331001
|
4.2
|
48.6
|
1.0
|
SD
|
A:MET364
|
4.2
|
40.7
|
1.0
|
CG2
|
A:VAL339
|
4.4
|
31.0
|
1.0
|
CG1
|
A:VAL339
|
4.4
|
32.6
|
1.0
|
C12
|
A:Q331001
|
4.5
|
55.1
|
1.0
|
CG2
|
A:ILE341
|
4.6
|
42.5
|
1.0
|
CB
|
A:ALA285
|
4.7
|
40.3
|
1.0
|
C5
|
A:Q331001
|
4.9
|
55.8
|
1.0
|
CG
|
A:MET364
|
5.0
|
37.7
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 8b8z
Go back to
Chlorine Binding Sites List in 8b8z
Chlorine binding site 3 out
of 4 in the Crystal Structure of Mutant Pparg (C313A) and NCOR2 with An Inverse Agonist (Compound 7E)
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Crystal Structure of Mutant Pparg (C313A) and NCOR2 with An Inverse Agonist (Compound 7E) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl1001
b:75.5
occ:1.00
|
CL16
|
B:Q331001
|
0.0
|
75.5
|
1.0
|
C15
|
B:Q331001
|
1.7
|
77.4
|
1.0
|
C14
|
B:Q331001
|
2.6
|
74.3
|
1.0
|
C17
|
B:Q331001
|
2.8
|
76.3
|
1.0
|
CL1
|
B:Q331001
|
3.2
|
86.8
|
1.0
|
CD2
|
B:LEU353
|
3.7
|
45.2
|
1.0
|
C12
|
B:Q331001
|
3.9
|
77.8
|
1.0
|
SD
|
B:MET348
|
3.9
|
66.2
|
1.0
|
CG2
|
B:ILE281
|
4.0
|
63.0
|
1.0
|
CD1
|
B:LEU353
|
4.0
|
42.7
|
1.0
|
C10
|
B:Q331001
|
4.0
|
79.9
|
1.0
|
CZ
|
B:PHE363
|
4.4
|
81.9
|
1.0
|
CG
|
B:MET364
|
4.4
|
53.6
|
1.0
|
C11
|
B:Q331001
|
4.5
|
79.0
|
1.0
|
CG
|
B:LEU353
|
4.5
|
43.3
|
1.0
|
CG1
|
B:VAL339
|
4.5
|
38.4
|
1.0
|
CG2
|
B:ILE341
|
4.6
|
58.2
|
1.0
|
SD
|
B:MET364
|
4.7
|
57.3
|
1.0
|
CE1
|
B:PHE363
|
5.0
|
86.2
|
1.0
|
CB
|
B:ALA285
|
5.0
|
50.0
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 8b8z
Go back to
Chlorine Binding Sites List in 8b8z
Chlorine binding site 4 out
of 4 in the Crystal Structure of Mutant Pparg (C313A) and NCOR2 with An Inverse Agonist (Compound 7E)
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Crystal Structure of Mutant Pparg (C313A) and NCOR2 with An Inverse Agonist (Compound 7E) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl1001
b:86.8
occ:1.00
|
CL1
|
B:Q331001
|
0.0
|
86.8
|
1.0
|
C17
|
B:Q331001
|
1.7
|
76.3
|
1.0
|
C10
|
B:Q331001
|
2.7
|
79.9
|
1.0
|
C15
|
B:Q331001
|
2.7
|
77.4
|
1.0
|
C2
|
B:Q331001
|
3.1
|
80.7
|
1.0
|
CL16
|
B:Q331001
|
3.2
|
75.5
|
1.0
|
O1
|
B:Q331001
|
3.3
|
75.3
|
1.0
|
SD
|
B:MET364
|
3.4
|
57.3
|
1.0
|
CE
|
B:MET364
|
3.7
|
59.5
|
1.0
|
C11
|
B:Q331001
|
4.0
|
79.0
|
1.0
|
C14
|
B:Q331001
|
4.0
|
74.3
|
1.0
|
N3
|
B:Q331001
|
4.0
|
76.0
|
1.0
|
CD2
|
B:LEU330
|
4.3
|
55.8
|
1.0
|
CD1
|
B:LEU330
|
4.3
|
50.5
|
1.0
|
CG
|
B:MET364
|
4.4
|
53.6
|
1.0
|
C12
|
B:Q331001
|
4.4
|
77.8
|
1.0
|
CB
|
B:ALA285
|
4.4
|
50.0
|
1.0
|
CG2
|
B:VAL339
|
4.7
|
39.5
|
1.0
|
CG
|
B:LEU330
|
4.8
|
50.4
|
1.0
|
CG1
|
B:VAL339
|
4.8
|
38.4
|
1.0
|
CE1
|
B:PHE363
|
4.9
|
86.2
|
1.0
|
C4
|
B:Q331001
|
5.0
|
73.2
|
1.0
|
|
Reference:
D.L.Orsi,
S.J.Ferrara,
S.Siegel,
A.Friberg,
L.Bouche,
E.Pook,
P.Lienau,
J.P.Bluck,
C.T.Lemke,
G.Akcay,
T.Stellfeld,
H.Meyer,
V.Putter,
S.J.Holton,
D.Korr,
I.Jerchel-Furau,
C.Pantelidou,
C.A.Strathdee,
M.Meyerson,
K.Eis,
J.T.Goldstein.
Discovery and Characterization of Orally Bioavailable 4-Chloro-6-Fluoroisophthalamides As Covalent Pparg Inverse-Agonists. Bioorg.Med.Chem. V. 78 17130 2022.
ISSN: ESSN 1464-3391
PubMed: 36542958
DOI: 10.1016/J.BMC.2022.117130
Page generated: Tue Jul 30 07:10:23 2024
|